✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Brigatinib

Brigatinib

CAS 1197953-54-0C29H39ClN7O2PMW 584.1

Brigatinib (CAS 1197953-54-0) — formula C29H39ClN7O2P, molecular weight 584.1.

Product Overview

CAS Number1197953-54-0
Molecular FormulaC29H39ClN7O2P
Molecular Weight584.1
LogP5.17

Technical Profile

What this product is

Brigatinib is a chemical compound with CAS registry number 1197953-54-0 and molecular formula C29H39ClN7O2P (molecular weight 584.1).

Identification

CAS number: 1197953-54-0

Its molecular formula C29H39ClN7O2P comprises 29 C, 39 H, 1 Cl, 7 N, 2 O, 1 P atoms.

Also known as: Brigatinib · 布加替尼

Frequently Asked Questions

What is the CAS number of Brigatinib?

The CAS registry number of Brigatinib is 1197953-54-0.

What is the molecular formula and molecular weight of Brigatinib?

Molecular formula C29H39ClN7O2P, molecular weight 584.1.

What other names is Brigatinib known by?

It is also registered under: Brigatinib, 布加替尼.

PubChem Public Data

Independent reference data for Brigatinib (CAS 1197953-54-0), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number1197953-54-0
PubChem CID68165256
Molecular formulaC29H39ClN7O2P
IUPAC name5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
UNII (FDA)HYW8DB273J

Computed descriptors

Molecular Weight584.1
XLogP34.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count8
Exact Mass583.2591382
Monoisotopic Mass583.2591382
Topological Polar Surface Area85.9
Heavy Atom Count40

Physicochemical values on record

LogP5.17

Documented uses on record

    Brigatinib is a tyrosine kinase receptor inhibitor and antineoplastic agent used in the therapy of selected forms of advanced non-small cell lung cancer. Brigatinib is associated with a moderate rate of transient elevations in serum aminotransferase levels during therapy but has yet to be linked to instances of clinically apparent acute liver injury.Breast Feeding; Lactation; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors; Tyrosine Kinase Inhibitors;

    Synonyms and trade names

    Brigatinib; 1197953-54-0; ALUNBRIG; AP-26113; HYW8DB273J; DTXSID501027929; brigatinibum; RefChem:56949; L01XE43; DTXCID501513495; AP 26113; Brigatinib [USAN]; Brigatinib (AP-26113); MFCD29472221; Brigatinib (AP26113); NCGC00483924-01

    GHS hazard classification

    Reported hazard statementsH301 (100%), H361 (100%), H372 (100%), H410 (100%)

    H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

    H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

    What the public record says

    Brigatinib · CAS 1197953-54-0 · C29H39ClN7O2P. UNII HYW8DB273J. LogP: 5.17.

    Physical description and handling notes

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 布加替尼

鲁ICP备19031700号-2